Article
Combination of ultrasound and molecular testing in malignancy risk estimate of Bethesda category IV thyroid nodules: results from a single-institution prospective study.
Journal of endocrinological investigation - 1 Dec 2021
Marina M, Zatelli M C, Goldoni M, Del Rio P, Corcione L, Martorana D, Percesepe A, Bonatti F, Mozzoni P, Crociara A, Ceresini G
Abstract excerpt
PURPOSE: Malignancy prediction in indeterminate thyroid nodules is still challenging. We prospectively evaluated whether the combination of ultrasound (US) risk stratification and molecular testing improves the assessment of malignancy risk in Bethesda Category IV thyroid nodules. METHODS: Ninety-one consecutively diagnosed Bethesda Category IV thyroid nodules were prospectively evaluated before surgery by both...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.